Phase 3 Ischemic Optic Neuropathy Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Non-arteritic Anterior Ischemic Optic Neuropathy
Dompé Farmaceutici S.p.A272 enrolled18 locationsNCT07453888
Not Yet Recruiting
Phase 3
Intravitreal Steroid for Anterior Ischemic Optic Nerve disease.
Non-arteritic Anterior Ischemic Optic Neuropathy
Khon Kaen University20 enrolled1 locationACTRN12612000344897
Active
Phase 2Phase 3
Efficacy of Memantine [N- Methyl- D- Aspartate (NMDA) receptor antagonist] versus placebo in acute non arteritic anterior ischemic optic neuropathy (NAION)
Non arteritic anterior ischemic optic neuropathy (NAION)
Tehran University of Medical sciences44 enrolled1 locationACTRN12607000181404